PepTivator® HHV-6 U39 Select

PepTivator® HHV-6 U39 Select, is a pool of lyophilized peptides, covering important MHC-I and MHC-II epitopes of the U39 (Envelope glycoprotein B, UniProt ID: P36320) of the human herpes virus type 6 (HHV-6) variant B.

In vitro stimulation of antigen-specific T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.

Related products for PepTivator® HHV-6 U39 Select

Specifications for PepTivator® HHV-6 U39 Select
Overview

PepTivator® HHV-6 U39 Select, is a pool of lyophilized peptides, covering important MHC-I and MHC-II epitopes of the U39 (Envelope glycoprotein B, UniProt ID: P36320) of the human herpes virus type 6 (HHV-6) variant B.

In vitro stimulation of antigen-specific T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and the up-regulation of activation markers, which then allow the detection and isolation of antigen-specific T cells.

Detailed product information
Background information

HHV-6 is a ubiquitous β-herpesvirus which is widespread among humans. It exists as two closely related variants: HHV-6A and HHV-6B, with HHV-6B being the primary cause of roseola infantum (exanthem subitum), while HHV-6A is less well characterized but has been associated with neurological diseases and multiple sclerosis. Both variants establish lifelong latency (a state where the viral genome persists without active production of infectious virions), mainly in mononuclear cells, and can reactivate, especially in immunocompromised individuals (e.g., transplant recipients). The HHV protein U39, also called Envelope glycoprotein B, is a highly conserved viral envelope protein that plays an essential role in viral entry, host cell membrane fusion, and viral propagation. The U39 sequence is highly conserved (> 95%) between HHV6A- and HHV6B-subtypes and abundantly expressed on the surface of mature virions, working in tandem with other glycoprotein complexes (like gH/gL/gQ1/gQ2) to build an infectious viral envelope.

The PepTivator Peptide Pools have been specially developed for efficient in vitro stimulation of antigen-specific CD4+ and CD8+ T cells in various applications. Stimulation of T cells with PepTivator Peptide Pools causes the secretion of effector cytokines and upregulation of activation markers, which then allows the detection or isolation of antigen-specific T cells. Quantitative, phenotypical, or functional analysis of antigen-specific T cell immunity can provide important information on the natural course of immune responses in healthy or immunocompromised individuals.